Table 3.
Country (Area) | Study Period | Type of Sample | Sampling Method | Number | Test | Cut-Off Value | Prevalence (%) | Reference |
---|---|---|---|---|---|---|---|---|
Canada | 2010–2012 | Serum | Multi-stage random | 76 | ELISA | 0.4 | 63.2 | [123] |
Great Britain | 2008 | Serum | Random stratified | 145 | ELISA | 0.4 | 3.0 | [124] |
Ireland (Republic of) | 2005–2007 | Serum | Random | 66 | ELISA | 0.4 | 1.5 | [125] |
Italy | 2012 | Serum | Multi-stage random | 206 | ELISA | 0.4 | 19.5 | [126] |
Lebanon | 2014 | Serum | Random | 128 | ELISA | 0.4 | 45.3 | [127] |
Norway | 2009 | BTM a | Random | 348 | ELISA | 0.4 | 0 | [128] |
Portugal | 2011 | Serum | Random | 52 | ELISA | 0.30 | 28.8 | [129] |
Spain | 2007–2008 | Serum | Random | 11 | ELISA | 0.40 | 45.0 | [130] |
Sweden | 2010 | BTM a | Random | 58 | ELISA | 0.4 | 1.7 | [131] |
Switzerland | 2011 | Serum | Random stratified | 72 | ELISA | 0.4 | 11.1 | [132] |
The Netherlands | 2008 | Serum | Random | 442 | ELISA | 0.4 | 17.9 | [133] |
USA | 2012–2014 | Serum | Random | 89 | ELISA | 0.4 | 11.5 | [115] |
a BTM—bulk tank milk.